Want to join the conversation?
$VRTX said that outside the U.S., reimbursement process for its cystic fibrosis treating drug Orkambi is ongoing. These discussions are progressing as anticipated by the company across Europe, Canada, and Australia. $VRTX believes that it will achieve reimbursements from European and other government payers as in the U.S.
Does anyone feel $SBUX CEO Schultz stepping down could prove a disaster for the company?
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.